Micro- and nano-vesicles from first trimester human placentae carry Flt-1 and levels are increased in severe preeclampsia

Frontiers in Endocrinology

Volumn 8, Issue JUL, 2017, Pages

  Tong, Mancy ^a,b   Chen, Qi ^a   James, Joanna L ^a   Stone, Peter R ^a   Chamley, Lawrence W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial dysfunction; Exosome, vesicle; Particle; Preeclampsia; Trophoblast; Vascular endothelial growth factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; NANOPARTICLE;

ARTICLE; CELL ACTIVATION; CELL ADHESION ASSAY; CELL FRACTIONATION; CELL SURFACE; CELL VACUOLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HYPERTENSION; MONOCYTE; PLACENTA; PREECLAMPSIA; PREGNANCY; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

EID: 85025619843     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.00174     Document Type: Article

References (57)

1. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol (1999) 180(2 Pt 1):499-506. doi:10.1016/S0002-9378(99)70239-5
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet (2005) 365(9461):785-99. doi:10.1016/S0140-6736(05)71003-5
3. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol (1989) 161(5):1200-4. doi:10.1016/0002-9378(89)90665-0
4. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol (1998) 16(1):5-15. doi:10.1055/s-2007-1016248
5. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation (2011) 123(24):2856-69. doi:10.1161/CIRCULATIONAHA.109.853127
6. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol (2014) 10(8):466-80. doi:10.1038/nrneph.2014.102
7. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol (2013) 122(5):1122-31. doi:10.1097/01.AOG.0000437382.03963.88
8. Lee E. Gross early enlargement of a hydatidiform mole with severe pre-eclampsia. Can Med Assoc J (1965) 93(2):79-80
9. Kristoffersen K, Jorgensen FS. A case of hydatidiform mole with severe preeclampsia and severe disturbances in thyroid function. Acta Obstet Gynecol Scand (1970) 49(2):119-23. doi:10.3109/00016347009158041
10. Maynard S, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 111(5):649-58. doi:10.1172/JCI17189
11. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 350(7):672-83. doi:10.1056/NEJMoa031884
12. Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenat Diagn (2008) 28(3):175-9. doi:10.1002/pd.1916
13. Lee E, Oh MJ, Jung JW, Lim JE, Seol HJ, Lee KJ, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci (2007) 22(1):94-8. doi:10.3346/jkms.2007.22.1.94
14. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 125(7):911-9. doi:10.1161/CIRCULATIONAHA.111.054361
15. Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, et al. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med (2014) 27(2):132-44. doi:10.3109/14767058.2013.806905
16. Sarker S, Scholz-Romero K, Perez A, Illanes SE, Mitchell MD, Rice GE, et al. Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. J Transl Med (2014) 12:204. doi:10.1186/1479-5876-12-204
17. Tannetta D, Dragovic R, Alyahyaei Z, Southcombe J. Extracellular vesicles and reproduction-promotion of successful pregnancy. Cell Mol Immunol (2014) 11(6):548-63. doi:10.1038/cmi.2014.42
18. Tong M, Chamley LW. Placental extracellular vesicles and feto-maternal communication. Cold Spring Harb Perspect Med (2015) 5(3):a023028. doi:10.1101/cshperspect.a023028
19. Attwood HD, Park WW. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw (1961) 68:611-7. doi:10.1111/j.1471-0528.1961.tb02778.x
20. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy-its relevance for pre-eclampsia. Placenta (1999) 20(7):531-9. doi:10.1053/plac.1999.0422
21. Buurma AJ, Penning ME, Prins F, Schutte JM, Bruijn JA, Wilhelmus S, et al. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung. Hypertension (2013) 62(3):608-13. doi:10.1161/HYPERTENSIONAHA.113.01505
22. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol (1998) 105(6):632-40. doi:10.1111/j.1471-0528.1998.tb10178.x
23. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta (2006) 27(1):56-61. doi:10.1016/j.placenta.2004.11.007
24. Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy (2008) 27(4):344-60. doi:10.1080/10641950801955733
25. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, Redman CW, et al. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta (2008) 29(11):942-9. doi:10.1016/j.placenta.2008.08.018
26. Chen Y, Huang Y, Jiang R, Teng Y. Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int J Gynaecol Obstet (2012) 119(3):234-8. doi:10.1016/j.ijgo.2012.07.010
27. Shen F, Wei J, Snowise S, DeSousa J, Stone P, Viall C, et al. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium. Placenta (2014) 35(10):839-47. doi:10.1016/j.placenta.2014.07.009
28. Tong M, Kleffmann T, Pradhan S, Johansson CL, DeSousa J, Stone PR, et al. Proteomic characterization of macro-, micro-and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication. Hum Reprod (2016) 31(4):687-99. doi:10.1093/humrep/dew004
29. Tannetta DS, Dragovic RA, Gardiner C, Redman CW, Sargent IL. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One (2013) 8(2):e56754. doi:10.1371/journal.pone.0056754
30. Abumaree MH, Stone PR, Chamley LW. The effects of apoptotic, deported human placental trophoblast on macrophages: possible consequences for pregnancy. J Reprod Immunol (2006) 72(1-2):33-45. doi:10.1016/j.jri.2006.03.001
31. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology (1992) 77(4):543-9
32. Chen Q, Stone PR, McCowan LM, Chamley LW. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension (2006) 47(1):116-21. doi:10.1161/01.HYP.0000196731.56062.7c
33. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol (1991) 98(10):973-9. doi:10.1111/j.1471-0528.1991.tb15334.x
34. Jacobs M, Nassar N, Roberts CL, Hadfield R, Morris JM, Ashton AW. Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reprod Biol Endocrinol (2011) 9:77. doi:10.1186/1477-7827-9-77
35. Tenney B Jr, Parker F Jr. The placenta in toxemia of pregnancy. Am J Obstet Gynecol (1940) 39(6):1000-5. doi:10.1016/S0002-9378(40)90458-6
36. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol (2000) 96(2):271-6. doi:10.1097/00006250-200008000-00022
37. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2001) 184(6):1249-50. doi:10.1067/mob.2001.112906
38. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta (2007) 28(Suppl A):S33-40. doi:10.1016/j.placenta.2007.06.008
39. Weber M, Gohner C, San Martin S, Vattai A, Hutter S, Parraga M, et al. Unique trophoblast stem cell-and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications. Cell Adh Migr (2016) 10(1-2):56-65. doi:10.1080/19336918.2016.1142035
40. Mincheva-Nilsson L, Baranov V. Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. Am J Reprod Immunol (2014) 72(5):440-57. doi:10.1111/aji.12311
41. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol (2006) 3:3.22. doi:10.1002/0471143030.cb0322s30
42. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 200(4):373-83. doi:10.1083/jcb.201211138
43. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol (1993) 100(10):943-9. doi:10.1111/j.1471-0528.1993.tb15114.x
44. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol (1997) 104(2):235-40. doi:10.1111/j.1471-0528.1997.tb11052.x
45. Gupta AK, Holzgreve W, Hahn S. Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Arch Gynecol Obstet (2008) 277(2):115-9. doi:10.1007/s00404-007-0425-2
46. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension (2012) 59(2):256-64. doi:10.1161/HYPERTENSIONAHA.111.182170
47. Gupta AK, Rusterholz C, Huppertz B, Malek A, Schneider H, Holzgreve W, et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta (2005) 26(1):59-66. doi:10.1016/j.placenta.2004.04.004
48. Baig S, Kothandaraman N, Manikandan J, Rong L, Ee KH, Hill J, et al. Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clin Proteomics (2014) 11(1):40. doi:10.1186/1559-0275-11-40
49. Cronqvist T, Salje K, Familari M, Guller S, Schneider H, Gardiner C, et al. Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS One (2014) 9(2):e90020. doi:10.1371/journal.pone.0090020
50. Chen Q, Ding JX, Liu B, Stone P, Feng YJ, Chamley L. Spreading endothelial cell dysfunction in response to necrotic trophoblasts. Soluble factors released from endothelial cells that have phagocytosed necrotic shed trophoblasts reduce the proliferation of additional endothelial cells. Placenta (2010) 31(11):976-81. doi:10.1016/j.placenta.2010.08.013
51. Shao J, Zhao M, Tong M, Wei J, Wise MR, Stone P, et al. Increased levels of HMGB1 in trophoblastic debris may contribute to preeclampsia. Reproduction (2016) 152(6):775-84. doi:10.1530/REP-16-0083
52. Tong M, Stanley J, Chen Q, Wise MR, Stone PR, James J, et al. In vivo targets of human placental extracellular vesicles. Reprod Sci (2016) 23(Suppl 1):153A
53. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res (2004) 95(9):884-91. doi:10.1161/01.RES.0000147365.86159.f5
54. Tong M, Chen Q, James JL, Wise MR, Stone PR, Chamley LW. In vivo targets of human placental micro-vesicles vary with exposure time and pregnancy. Reproduction (2017) 153(6):835-45. doi:10.1530/REP-16-0615
55. Sgambati E, Marini M, Zappoli Thyrion GD, Parretti E, Mello G, Orlando C, et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG (2004) 111(6):564-70. doi:10.1111/j.1471-0528.2004.00143.x
56. Akercan F, Cirpan T, Terek MC, Ozcakir HT, Giray G, Sagol S, et al. The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia. Arch Gynecol Obstet (2008) 277(2):109-14. doi:10.1007/s00404-007-0430-5
57. Smarason AK, Sargent IL, Redman CW. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol (1996) 174(2):787-93. doi:10.1016/S0002-9378(96)70466-0